U.S. flag

An official website of the United States government

GTR Home > Tests > DCMNext®

Indication

This is a clinical test intended for Help: Diagnosis, Pre-symptomatic

Clinical summary

Help

Imported from GeneReviews

LMNA-related dilated cardiomyopathy (DCM) is characterized by left ventricular enlargement and/or reduced systolic function preceded (sometimes by many years) by or accompanied by conduction system disease and/or arrhythmias. LMNA-related DCM usually presents in early to mid-adulthood with symptomatic conduction system disease or arrhythmias, or with symptomatic DCM including heart failure or embolus from a left ventricular mural thrombus. Sudden cardiac death can occur, and in some instances is the presenting manifestation; sudden cardiac death may occur with minimal or no systolic dysfunction.

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Atrial fibrillation
  • Atrial flutter
  • Primary dilated cardiomyopathy
  • Congestive heart failure
  • Pericardial effusion
  • Sudden cardiac death
  • Sinus bradycardia
  • Ventricular arrhythmia
  • First degree atrioventricular block
  • Third degree atrioventricular block
  • Second degree atrioventricular block
Show all

Inheritance pattern

Help

Autosomal dominant inheritance

Conditions tested

Target population

Help

Not provided

Clinical validity

Help

Clinical validity depends on specific clinical and family history.

Citations

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.